from Journal of Clinical Oncology
Pancreatic cancer, while relatively rare, kills more people than breast cancer. One reason is that pancreatic cancer is very difficult to detect in its early stages when treatment might be effective. That may soon change, thanks to a new blood test that can detect pancreatic cancer with ninety-si percent accuracy while there is still a chance for successful surgery. The blood test samples the immune system because it is the first to respond to threats like complex diseases, such as cancer, long before being visible on a CT scan. Authors of the study in the Journal of Clinical Oncology say the blood test could be used to screen people who are at higher risk of developing pancreatic cancer. The next step is already underway—a large prospective study for high-risk people.